Article Details

Theravance Biopharma (TBPH) Reports Q3 Loss, Lags Revenue Estimates - Zacks

Retrieved on: 2022-11-08 07:58:27

Tags for this article:

Click the tags to see associated articles and topics

Theravance Biopharma (TBPH) Reports Q3 Loss, Lags Revenue Estimates - Zacks. View article details on hiswai:

Excerpt

This quarterly report represents an earnings surprise of 4.55%. A quarter ago, it was expected that this biopharmaceutical company would post a loss ...

Article found on: www.zacks.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up